<unk>  (codenamed as BBV152) is an whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology. As of October 2021, 110.6 million people in India have received<unk> . On 3 November 2021, the World Health Organization (WHO) validated the vaccine for emergency use. As of 31 January 2022,<unk>  has been granted emergency use approval in 13 countries
Covaxin
Trafermin
Seviteronel
Rubitecan
Mecasermin
Dosulepin
Titermax
Itruvone